Cosmetic medicine is bringing a fresh face to interventional radiology with new minimally invasive applications and opportunities to profit from this highly lucrative field.
Cosmetic medicine is bringing a fresh face to interventional radiology with new minimally invasive applications and opportunities to profit from this highly lucrative field.
Cosmetic procedures could be a problem-solver for interventional radiologists, who are plagued by declining reimbursement and the pressure to generate more revenue for their groups, said Dr. Ziv J. Haskal, director of vascular and interventional radiology at Columbia University.
Haskal and Dr. Rodney Raabe, an interventionalist from Spokane, WA, hosted a one-day symposium on aesthetic medicine at the 2007 Society of Interventional Radiology meeting in March. Attendees learned that cosmetic medicine represents a billion-dollar business with an increasing demand but a short supply of qualified professionals. The list of procedures IRs could be doing includes Botox injections for facial wrinkles; injection of collagen and other dermal fillers for facial contouring; and laser-based removal of sun spots, acne, and hair. Skills developed by IRs for minimally invasive treatment of varicose veins and other unsightly vascular malformations are directly applicable to many of these cosmetic procedures sought by patients, Haskal said.
"This field reinvents itself again and again. Those who believe that this will not be part of interventional radiology practice may be the ones who said no in the past to other areas. You only need to learn from history," he said.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.